ZA200505728B - 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure - Google Patents

10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure

Info

Publication number
ZA200505728B
ZA200505728B ZA200505728A ZA200505728A ZA200505728B ZA 200505728 B ZA200505728 B ZA 200505728B ZA 200505728 A ZA200505728 A ZA 200505728A ZA 200505728 A ZA200505728 A ZA 200505728A ZA 200505728 B ZA200505728 B ZA 200505728B
Authority
ZA
South Africa
Prior art keywords
agents
acid derivatives
intraocular pressure
prostanoic acid
lowering intraocular
Prior art date
Application number
ZA200505728A
Other languages
English (en)
Inventor
Yariv Donde
Jeremiah H Nguyen
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of ZA200505728B publication Critical patent/ZA200505728B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA200505728A 2003-02-11 2005-07-18 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure ZA200505728B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/365,369 US6875787B2 (en) 2003-02-11 2003-02-11 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure

Publications (1)

Publication Number Publication Date
ZA200505728B true ZA200505728B (en) 2006-04-26

Family

ID=32824631

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200505728A ZA200505728B (en) 2003-02-11 2005-07-18 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure

Country Status (13)

Country Link
US (2) US6875787B2 (xx)
EP (2) EP2263674B1 (xx)
CN (3) CN102050811A (xx)
AR (1) AR043138A1 (xx)
CY (1) CY1113138T1 (xx)
DK (2) DK1608309T3 (xx)
ES (2) ES2391393T3 (xx)
HK (1) HK1086191A1 (xx)
IL (1) IL170052A (xx)
PT (1) PT1608309E (xx)
SI (1) SI1608309T1 (xx)
TW (1) TWI329631B (xx)
ZA (1) ZA200505728B (xx)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7855226B2 (en) * 2003-02-11 2010-12-21 Allergan, Inc. Treatment of inflammatory bowel disease
US7169807B2 (en) * 2004-04-09 2007-01-30 Allergan, Inc. 10-Hydroxy-11-dihydroprostaglandin analogs as selective EP4 agonists
US20080132543A1 (en) * 2004-10-26 2008-06-05 Wha Bin Im Therapeutic and Delivery Methods of Prostaglandin Ep4, Agonists
US7101906B2 (en) 2004-11-16 2006-09-05 Allergan, Inc. 2,3,4-substituted cyclopentanones as therapeutic agents
TWI386208B (zh) * 2005-04-18 2013-02-21 Allergan Inc 治療性的經取代環戊酮
US7893107B2 (en) * 2005-11-30 2011-02-22 Allergan, Inc. Therapeutic methods using prostaglandin EP4 agonist components
US20070232660A1 (en) * 2006-04-04 2007-10-04 Allergan, Inc. Therapeutic and delivery methods of prostaglandin ep4 agonists
US9308070B2 (en) 2008-12-15 2016-04-12 Allergan, Inc. Pliable silk medical device
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
US20110052695A1 (en) * 2009-04-20 2011-03-03 Allergan, Inc. Drug delivery platforms comprising silk fibroin hydrogels and uses thereof
US20110111031A1 (en) * 2009-04-20 2011-05-12 Guang-Liang Jiang Drug Delivery Platforms Comprising Silk Fibroin Hydrogels and Uses Thereof
WO2010123946A2 (en) 2009-04-20 2010-10-28 Allergan, Inc. Silk fibroin hydrogels and uses thereof
NZ607306A (en) 2010-07-30 2015-03-27 Allergan Inc Compounds and methods for skin repair
KR20140003395A (ko) 2010-08-17 2014-01-09 알러간, 인코포레이티드 각막 혼탁 치료용 ep2 또는 ep4 항진제들
WO2012024072A1 (en) * 2010-08-19 2012-02-23 Allergan, Inc. Compositions comprising adipose tissue and a pge2 analogue and their use in the treatment of a soft tissue condition
US8741281B2 (en) * 2010-08-19 2014-06-03 Allergan, Inc. Compositions and soft tissue replacement methods
US8697057B2 (en) * 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods
US20120142684A1 (en) 2010-12-02 2012-06-07 Allergan, Inc. Compounds and methods for skin repair
EP2675491A2 (en) 2011-02-17 2013-12-25 Allergan, Inc. Compositions and improved soft tissue replacement methods
WO2013105997A2 (en) 2011-02-23 2013-07-18 Allergan, Inc. Compositions and improved soft tissue replacement methods
CA2832589A1 (en) 2011-04-07 2012-10-11 Allergan, Inc. Devices, compositions and methods utilizing ep4 and ep2 receptor agonists for preventing, reducing or treating capsular contracture
EP2814482A1 (en) 2012-02-16 2014-12-24 Allergan, Inc. Compositions and improved soft tissue replacement methods
WO2013123275A1 (en) 2012-02-16 2013-08-22 Allergan, Inc. Compositions and improved soft tissue replacement methods
WO2013123272A1 (en) 2012-02-16 2013-08-22 Allergan, Inc. Compositions and improved soft tissue replacement methods
WO2013123274A1 (en) 2012-02-16 2013-08-22 Allergan, Inc. Compositions and improved soft tissue replacement methods
CN106062303B (zh) 2014-03-07 2019-05-14 德国德力能有限公司 用于将引爆器定位在射孔枪组件内的装置和方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117014A (en) * 1976-01-09 1978-09-26 Abbott Laboratories Prostaglandin derivatives
JPS59101458A (ja) * 1982-12-01 1984-06-12 Nippon Iyakuhin Kogyo Kk 新規なチアプロスタグランジン誘導体及びその製法
JPS632972A (ja) * 1986-06-20 1988-01-07 Nippon Iyakuhin Kogyo Kk 新規プロスタグランジンｅ↓１誘導体及びその製法
US6187813B1 (en) * 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
AU635294B2 (en) * 1989-07-27 1993-03-18 Allergan, Inc. Intraocular pressure reducing 9,11-diacyl prostaglandins
US5028624A (en) 1989-07-27 1991-07-02 Allergan, Inc. Intraocular pressure reducing 9,15-diacyl prostaglandins
CA2021316C (en) * 1989-07-27 2000-10-24 Ming Fai Chan Intraocular pressure reducing 11-acyl prostaglandins
US5034413A (en) * 1989-07-27 1991-07-23 Allergan, Inc. Intraocular pressure reducing 9,11-diacyl prostaglandins
CA2020254A1 (en) * 1989-07-27 1991-01-28 Ming F. Chan Intraocular pressure reducing 9, 15-diacyl prostaglandins
US4994274A (en) * 1989-07-27 1991-02-19 Allergan, Inc. Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using
US6034413A (en) * 1997-02-27 2000-03-07 Texas Instruments Incorporated High speed biCMOS gate power for power MOSFETs incorporating improved injection immunity
DE10057158C1 (de) * 2000-11-16 2002-03-28 Asglawo Gmbh Stoffe Zum Daemme Lagerungsmatte für die Lagerung eines Abgaskatalysators
US6531504B2 (en) * 2001-05-17 2003-03-11 Allergan, Inc. Prostanoic acid derivatives as agents for lowering intraocular pressure
NZ532519A (en) * 2001-11-05 2006-11-30 Allergan Inc Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists
US7175476B2 (en) * 2005-01-11 2007-02-13 Daeun Electronics Co., Ltd. Crosstalk canceling pattern for high-speed communications and modular jack having the same

Also Published As

Publication number Publication date
US20040157901A1 (en) 2004-08-12
HK1086191A1 (en) 2006-09-15
DK2263674T3 (da) 2014-10-27
EP2803358B1 (en) 2017-05-03
ES2515217T3 (es) 2014-10-29
AR043138A1 (es) 2005-07-20
TW200512184A (en) 2005-04-01
DK1608309T3 (da) 2012-09-03
US6875787B2 (en) 2005-04-05
EP2803358A1 (en) 2014-11-19
TWI329631B (en) 2010-09-01
ES2391393T3 (es) 2012-11-23
CY1113138T1 (el) 2016-04-13
EP2263674B1 (en) 2014-07-23
CN102050812A (zh) 2011-05-11
IL170052A (en) 2011-10-31
EP2263674A1 (en) 2010-12-22
CN1758915A (zh) 2006-04-12
PT1608309E (pt) 2012-10-18
US20040235958A1 (en) 2004-11-25
SI1608309T1 (sl) 2012-11-30
CN102050812B (zh) 2015-02-18
CN102050811A (zh) 2011-05-11

Similar Documents

Publication Publication Date Title
ZA200505728B (en) 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure
HK1072603A1 (en) 8-azaprostaglandin analogs as agents for lowering intraocular pressure 8-
NO20053715D0 (no) 10,10-dialkylprostanoinsyrederivater som midler for a senke intraokulaert trykk
HK1093503A1 (en) Pyrido 2, 1-a-isoquinoline derivatives as ddp-IV inhibitors
IL183568A (en) Process for making 7,8-dihydro-5 h-patridine-6-onh
MX268884B (es) Derivados de merocianina para uso cosmetico.
EP1732634A4 (en) EYE PRESSURE CONTROL
PL369531A1 (en) 1,8-naphthyridine derivatives as antidiabetics
HK1155146A1 (zh) 作為藥物活性劑的茚衍生物
PL378342A1 (pl) Pochodne 2-piperydonu jako agoniści prostaglandyn
ZA200506744B (en) PyrazoloÄ1,5-AÜpyrimidine derivatives
AU2003231942A1 (en) Aqueous suspension agent for water insoluble compounds
EP1809613A4 (en) PROCESSES FOR PRODUCING 2,6-DIARYLE PIPERIDINE DERIVATIVES
IL164516A0 (en) 2,6-Quimolinyl and 2,6-naphthyl derivatives, processes for preparation them and their uses as vla-4 inhibitors
IL166698A0 (en) Process for preparing paste-extruded sulfonamide compositions
HK1108580A1 (en) A process for the preparation of [1,4,5]-oxadiazepine derivatives
HK1086008A1 (en) Process for preparing substituted 5-amino-pyrazolo-Ä4,3-eÜ-1,2,4-triazoloÄ1,5-cÜpyrimidines
PL373624A1 (en) 4-[7-halo-2-quino (xa-) linyloxy]phenoxy-propionic acid derivatives as antineoplastic agents
AU2003282804A1 (en) 3-(3,5-disubstituted-4-hydroxyphenyl)propionamide derivatives as cathepsin b inhibitors
IL182314A0 (en) 1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives
ZA200703562B (en) 1,5-diheterocycle-1H-triazole derivative
AU2003232108A8 (en) 1,1- and 1,2-bisphosphonates as apoliprotein e modulators
IL164240A0 (en) 1,3,5-Triazine derivatives as ligands for human adanosine-a3 receptors
SI1699747T1 (sl) Postopek za pripravo 2,3-cis-substituiranih 2-arilopropenalov
EP1711189A4 (en) AZALIDE DERIVATIVES 8A 6,11-3C-BICYCLIC